Cell and Organ Transplantology. 2015; 3(1): 46-51.
Effects of human Wharton’s jelly-derived mesenchymal stem cells and Interleukin-10 on behavioural responses of rats with experimental allergic encephalomyelitis
Tsymbaliuk V. I.1, Velychko O. M.1, Pichkur O. L.1, Verbovska S. A.1, Pichkur L. D.1, Shuvalova N. S.2
1A. P. Romodanov State Institute of Neurosurgery NAMS Ukraine, Kyiv, Ukraine
2State Institute of Genetic and Regenerative Medicine NAMS Ukraine, Kyiv, Ukraine
On the rat model of experimental allergic encephalomyelitis (EAE), as analogue of multiple sclerosis of human, we studied the effect of Wharton’s jelly-derived mesenchymal stem cells and interleukin-10 on the functional parameters of the CNS.
Materials and methods. EAE was induced with spinal cord homogenate of rats with complete Freund’s adjuvant. MSCs were isolated by the explants technique from Wharton’s jelly of the human umbilical cord and cultured up to two passages. Recombinant IL-10 was administered intravenously on the day 10 after induction of EAE and subocipitally on the day 17 at a dose of 0.2 mg per animal. Cell transplantation performed subocipitally on the day 17 at a dose of 106 cells per animal. Behavioral reactions studied in the “open field” test three times: on the day 12, 15 and 24 after the induction of EAE.
Results. Induced EAE results in significant changes in adaptive behavior of rats on the 12th day as suppression of orienting-exploratory and activation of emotional activity. The application of MSCs and IL-10 has normalized the rates of cognitive activities (orienting-exploratory activity) and emotional sphere (the level of fear, anxiety).
Conclusion. Combined treatment of induced EAE in rats with interleukin-10 and human Wharton’s jelly-derived mesenchymal stem cells is effective at correction of behavioral responses of animals.
Key words: experimental allergic encephalomyelitis; Wharton’s jelly-derived mesenchymal stem cells; interleukin-10; “open field” testFull Text PDF (eng) Full Text PDF (ua)
|1. Augello A, Kurth T B, De Bari C. Mesenchymal stem cells: a perspective from in vitro cultures to in vivo migration and niche. Eur. Cell Mater. 2010; 20:121 – 133.
|2. Bieback K, Brinkmann I. Mesenchymal stromal cells from human perinatal tissues: From biology to cell therapy. World J. Stem Cells. 2010; 2(4):81 – 92.
|3. Wang Z, Li Y, Ahmad A, et al. Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance. Drug Resistance Updates. 2010; 13(4–5):109 – 118.
|4. Thiery J-P, Acloque H, Huang R Y J, et al. Epithelial-Mesenchymal Transitions in Development and Disease. Cell. 2009; 139(5):871 – 890.
|6. Kalluri J. EMT: When epithelial cells decide to become mesenchymal-like cells. J. Clin. Invest. 2009; 119(6):1417 – 1419.
|7. Selezneva T, Mishyn A, Barsukow V. Gistologiya: polnyi kurs za tri dnya [Histology: A full course of 3 days]. Moscow, Eksmo, 2007. 354 p. In Russian.|
|8. Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat. Rev. Cancer. 2006; 6(5):392 – 401.
|9. Patel A, Park E, Kuzman M, et al. Multipotent Menstrual Blood Stromal Stem Cells: Isolation, Characterization, and Differentiation. Cell Transplantation. 2008; 17(3):303 – 311.
|10. Huang GT-J, Gronthos S, Shi S. Mesenchymal Stem Cells Derived from Dental Tissues vs. Those from Other Sources: Their Biology and Role in Regenerative Medicine. JDR. 2009; 88(9):792 – 806.
|11. Taghizadeh RR, Cetrulo KJ, Cetrulo CL. Wharton’s Jelly stem cells: Future clinical applications. Placenta. 2011; 32(4):311 – 315.
|12. Maslova OO, Shuvalova NS, Sukhorada OM, et al. Heterogeneity of Umbilical Cords as a Source for MSC. Dataset Papers in Biology. 2013; Article ID 370103, http://dx.doi.org/10.7167/2013/370103.
|13. Tang YL, Zhang YC, Qian K, et al. Improved Graft Mesenchymal Stem Cell Survival in Ischemic Heart With a Hypoxia-Regulated Heme Oxygenase-1 Vector. J. Am. Coll.Cardiol. 2005; 46(7):1339–1350.
|14. Lalani I, Bhol K, Ahmed AR. Interleukin-10: biology, role in inflammation and autoimmunity. Ann. Allergy. 1997; 79:469–483.
|15. Zhang X, Koldzic DN, Izikson L, et al. IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T-cells. Int. Immunol. 2004; 16(2):249–256.
|16. Segal BM, Dwyer BK, Shevach EM. An Interleukin (IL)-10/IL-12 Immunoregulatory Circuit Controls Susceptibility to Autoimmune Disease. J. Exp. Med. 1998; 187(4):537–546.
|17. Bettelli E, Das MP, Howard ED, et al. IL-10 Is Critical in the Regulation of Autoimmune Encephalomyelitis as Demonstrated by Studies of IL-10- and IL-4-Deficient and Transgenic Mice.J. Immunol. 1998; 161:3299–3306.
|18. European convention for the protection of vertebrate animals used for experimental and other scientific purposes. Council of European. Strasbourg, 1986. 51 р.|
|21. Tsymbaliuk VI. Osoblyvosti modeljuvannja ta perebigu eksperymental’nogo alergichnogo encefalomijelitu [Features and flow modeling of experimental allergic encephalomyelitis]. Ukr. nejrohirurgichnyj zhurnal – Ukrainian Journal of Neurosurgical, 2005; 1:12–14. In Ukranian.|
|22. Kasyanenko YuA. Vplyv suspenzii’ klityn fetal’nogo mozku na perebig eksperymental’nogo alergichnogo encefalomijelitu : avtoref. dys. na zdobuttja nauk. stupenja kand. med. nauk: spec. 14.01.05. «Nejrohirurgija» [The impact of fetal brain cell suspension in the course of experimental allergic encephalomyelitis: abstract thesis]. Kyiv – Kyiv, 2006. 20 p. In Ukranian.|
Tsymbaliuk VI, Velychko OM, Pichkur OL, Verbovska SA, Pichkur LD, Shuvalova NS. Effects of human Wharton’s jelly-derived mesenchymal stem cells and interleukin-10 on behavioural responses of rats with experimental allergic encephalomyelitis. Cell and Organ Transplantology. 2015; 3(1):46-51. doi: 10.22494/COT.V3I1.19